NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

NVAX

Novavax, Inc

Jul 03 • 04:00PM ET

6.80

Dollar change +0.04
Percentage change 0.59	%

Healthcare • Biotechnology • USA • NASD

Peers: MRNA BNTX PFE JNJ AZN GSK SNY INO NVCR VIR

| Held by: VTI VB IWM XBI VXF VBK IWO IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	2.56	EPS (ttm)	2.65	Insider Own	8.91%	Shs Outstand	161.96M	Perf Week	4.62%
Market Cap	1.10B	Forward P/E	29.97	EPS next Y	0.23	Insider Trans	0.00%	Shs Float	147.54M	Perf Month	-6.34%
Enterprise Value	587.90M	PEG	-	EPS next Q	-0.06	Inst Own	56.79%	Short Float	30.15%	Perf Quarter	13.71%
Income	478.70M	P/S	0.88	EPS this Y	298.25%	Inst Trans	-4.89%	Short Ratio	4.98	Perf Half Y	-14.25%
Sales	1.25B	P/B	-	EPS next Y	-90.69%	ROA	36.18%	Short Interest	44.48M	Perf YTD	-15.42%
Book/sh	-0.47	P/C	1.48	EPS next 5Y	-	ROE	-	52W High	17.81 -61.82%	Perf Year	-46.58%
Cash/sh	4.58	P/FCF	-	EPS past 3/5Y	62.54% 25.88%	ROIC	324.46%	52W Low	5.01 35.73%	Perf 3Y	-86.68%
Dividend Est.	-	EV/EBITDA	1.26	Sales past 3/5Y	-15.89% 105.39%	Gross Margin	87.18%	Volatility	5.22% 4.93%	Perf 5Y	-91.86%
Dividend TTM	-	EV/Sales	0.47	EPS Y/Y TTM	198.04%	Oper. Margin	33.69%	ATR (14)	0.38	Perf 10Y	-96.96%
Dividend Ex-Date	Dec 13, 2007	Quick Ratio	2.03	Sales Y/Y TTM	25.92%	Profit Margin	38.14%	RSI (14)	51.68	Recom	2.71
Dividend Gr. 3/5Y	- -	Current Ratio	2.06	EPS Q/Q	376.87%	SMA20	0.68%	Beta	2.49	Target Price	13.43
Payout	-	Debt/Eq	-	Sales Q/Q	610.30%	SMA50	0.38%	Rel Volume	0.26	Prev Close	6.76
Employees	952	LT Debt/Eq	-	Earnings	May 08 BMO	SMA200	-19.24%	Avg Volume	8.93M	Price	6.80
IPO	Dec 05, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	792.18% 93.88%	Trades		Volume	2,288,557	Change	0.59%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-17-25	Initiated	Citigroup	Sell	$6
Feb-28-25	Initiated	BTIG Research	Buy	$19
Jul-30-24	Downgrade	JP Morgan	Neutral → Underweight	$8
May-10-24	Upgrade	JP Morgan	Underweight → Neutral
May-10-24	Upgrade	BofA Securities	Underperform → Neutral	$4 → $12
Aug-09-23	Upgrade	B. Riley Securities	Neutral → Buy	$15
Apr-20-23	Downgrade	TD Cowen	Outperform → Market Perform	$55 → $10
Mar-01-23	Downgrade	B. Riley Securities	Buy → Neutral	$29 → $10
Jan-09-23	Reiterated	B. Riley Securities	Buy	$74 → $37
Dec-30-22	Reiterated	H.C. Wainwright	Buy	$207 → $110
Dec-02-22	Initiated	Jefferies	Hold
Sep-22-22	Downgrade	JP Morgan	Neutral → Underweight	$132 → $27
May-20-22	Initiated	BofA Securities	Underperform	$35
Feb-23-22	Reiterated	B. Riley Securities	Buy	$315 → $265
Feb-22-22	Resumed	Jefferies	Buy	$198
Jan-21-22	Initiated	Cowen	Outperform	$150
May-12-21	Downgrade	JP Morgan	Overweight → Neutral	$285 → $161
Dec-14-20	Initiated	Jefferies	Buy	$200
Aug-06-20	Reiterated	H.C. Wainwright	Buy	$132 → $290
Aug-05-20	Upgrade	JP Morgan	Neutral → Overweight	$275

Show Previous Ratings

Jul-01-25 09:00AM	Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now? (Zacks)
06:53AM	Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? (Zacks)
Jun-27-25 05:45PM	Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Jun-24-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jun-20-25 05:45PM	Novavax (NVAX) Ascends While Market Falls: Some Facts to Note (Zacks)
09:00AM	Loading…
Jun-19-25 09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jun-18-25 09:51AM	Roku upgraded, Sarepta downgraded: Wall Streets top analyst calls (TipRanks)
Jun-17-25 12:57PM	Citi initiates coverage on biotech amid improving sentiment in sector (Investing.com) -7.68%
Jun-12-25 11:30AM	Why Is Fate Therapeutics (FATE) Up 61.5% Since Last Earnings Report? (Zacks)
08:15AM	Novavax's COVID-Flu Combo Shot Shows Strong Immune Response (Zacks)
Jun-11-25 10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
10:20AM	Kennedy Pledges to Immediately Replace Vaccine Advisors, Shortcutting Vetting Process (Barrons.com)
09:50AM	Novavax (NVAX) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
07:11AM	Novavax's COVID-flu combo vaccine shows strong immune response in trial (Reuters)
07:11AM	Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study (Reuters)
07:00AM	Loading…
07:00AM	Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial (PR Newswire)
Jun-10-25 04:10PM	Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee (Investor's Business Daily)
10:10AM	RFK Jr. removes CDC vaccine panel members: What to know (Yahoo Finance Video)
Jun-09-25 06:07PM	Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. (Investor's Business Daily)
Jun-06-25 09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks) +6.58%
Jun-03-25 12:16PM	Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike (Zacks)
May-29-25 08:00AM	Novavax to Participate in Upcoming Investor Conferences (PR Newswire)
May-26-25 09:50AM	Here's Why Novavax (NVAX) is a Strong Momentum Stock (Zacks)
09:41AM	MRNA Seeks FDA Nod for Updated COVID-19 Vaccine (Zacks)
09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
May-23-25 07:45AM	Analysts Think These Stocks Could More Than Double in Value (MarketBeat)
May-22-25 02:30PM	FDA panel recommends keeping COVID shots targeted to same strain as last year (BioPharma Dive)
12:35PM	Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More (Zacks)
10:48AM	MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot (Zacks)
May-21-25 01:30PM	BofA Reiterates Hold Rating on Novavax (NVAX) Stock (Insider Monkey) -7.42%
11:10AM	Loading…
11:10AM	FDA to mandate trials for COVID boosters for healthy kids and adults (TipRanks)
May-20-25 03:55PM	COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers (Yahoo Finance Video)
12:22PM	The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped. (Investor's Business Daily)
04:59AM	Company News for May 20, 2025 (Zacks)
04:00AM	The placebo effect: How a new FDA rule could pile more strain onto vaccine developers (Pharma Voice)
May-19-25 05:18PM	S&P 500 Gains & Losses Today: Solar Stocks Fall, UnitedHealth Shares Jump (Investopedia) +15.01%
04:30PM	JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News (Insider Monkey)
03:44PM	Novavax, Shake Shack, solar stocks: Trending Tickers (Yahoo Finance Video)
03:42PM	Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine (GuruFocus.com)
11:55AM	Top Stock Movers Now: Tesla, AutoZone, Novavax, and More (Investopedia)
10:46AM	Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers (Yahoo Finance Video)
10:30AM	Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. (Barrons.com)
09:43AM	RFK Jr. pledged not to upend US vaccine system, but big changes are underway (Associated Press Finance)
09:42AM	NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine (Zacks)
09:39AM	Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine (Investopedia)
07:16AM	Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine (Reuters)
07:00AM	U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine (PR Newswire)
May-18-25 08:53PM	FDA Clears Novavax, Inc. (NVAX)'s COVID-19 Vaccine with Usage Restrictions (Insider Monkey)
May-17-25 10:21PM	FDA approves Novavax COVID-19 shot but with unusual restrictions (Associated Press Finance)
May-13-25 09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
May-09-25 09:50AM	Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term (Zacks) -10.29%
08:55AM	NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up (Zacks)
03:13AM	Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... (GuruFocus.com)
May-08-25 01:55PM	Why This Shrinking Covid-19 Vaccine Stock Jumped 30% (Barrons.com) +11.93%
01:31PM	COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why (Benzinga)
12:15PM	Novavax Hauls in $666M Q1 Windfall, Boosts FY25 Outlook (GuruFocus.com)
09:15AM	Novavax (NVAX) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:14AM	Novavax: Q1 Earnings Snapshot (Associated Press Finance)
08:06AM	Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears (Reuters)
08:00AM	Novavax Reports First Quarter 2025 Financial Results and Operational Highlights (PR Newswire)
May-07-25 06:00PM	Niagen Bioscience (NAGE) Q1 Earnings and Revenues Beat Estimates (Zacks)
11:56AM	Novavax Q1 2025 Earnings Preview (Seeking Alpha)
08:00AM	Novavax to Participate in BofA Securities 2025 Health Care Conference (PR Newswire)
May-05-25 12:12PM	ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards? (Zacks)
09:54AM	Perrigo to Report Q1 Earnings: Is a Beat in Store for the Stock? (Zacks)
08:00AM	Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid in Japan (PR Newswire)
07:12AM	Novavax to Report First-Quarter Earnings: Is a Beat in Store? (Zacks)
May-02-25 05:45PM	Novavax (NVAX) Flat As Market Gains: What You Should Know (Zacks)
10:00AM	ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
May-01-25 08:00AM	Novavax to Report First Quarter 2025 Financial Results on May 8, 2025 (PR Newswire)
Apr-29-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:00AM	Novavax Appoints Charles Newton to Board of Directors (PR Newswire)
Apr-28-25 04:58PM	FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots (Associated Press Finance)
02:21PM	Nvidia & chip stocks falling, Novavax vaccine, Zscaler upgrade (Yahoo Finance Video)
01:50PM	Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. (Barrons.com)
11:38AM	Novavax Stock Is Up Again on Speculation Over the Fate of Its Covid Shot (Barrons.com)
09:04AM	Zoetis Gears Up to Report Q1 Earnings: Here's What to Expect (Zacks)
08:45AM	Novavax: Grandiose Ambitions, Smart Strategy, But FDA Decision Adds To Challenges (Seeking Alpha)
08:16AM	Novavax says vaccine application still approvable, despite FDA delay (BioPharma Dive)
Apr-25-25 03:20PM	FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot (The Wall Street Journal) -5.66%
11:16AM	Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards? (Zacks)
10:14AM	CytomX Gears Up to Report Q1 Earnings: Here's What to Expect (Zacks)
09:25AM	Beam Therapeutics to Report Q1 Earnings: What's in the Cards? (Zacks)
Apr-24-25 01:48AM	Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? (Zacks) -5.35%
Apr-23-25 04:04PM	Novavax Shares Surge 17% as FDA Requests Postmarketing Data for COVID-19 Vaccine (GuruFocus.com) +19.52%
12:16PM	Vertiv earnings beat, DOJ & DisneyfuboTV deal, Novavax COVID shot (Yahoo Finance Video)
10:51AM	Novavax says its COVID-19 shot is on track for full FDA approval after delay (Associated Press Finance)
09:25AM	Amicus Therapeutics to Report Q1 Earnings: What's in the Cards? (Zacks)
09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:56AM	Novavax Jumps After FDA Asks for More Data on Its Covid Vaccine (Bloomberg)
Apr-22-25 10:39AM	Verastem Oncology to Report Q1 Earnings: What's in the Cards? (Zacks)
06:00AM	Akeso claims another PD-1/VEGF win; FDA requests more data from Novavax (BioPharma Dive)
Apr-21-25 05:45PM	Why the Market Dipped But Novavax (NVAX) Gained Today (Zacks)
07:36AM	Viking Therapeutics to Report Q1 Earnings: What's in the Cards? (Zacks)
Apr-17-25 10:51AM	Vaccine Stocks Rise on Growing Threat of Bird Flu Infections (Zacks)
Apr-15-25 05:45PM	Here's Why Novavax (NVAX) Fell More Than Broader Market (Zacks)
07:00AM	SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA (PR Newswire)
Apr-11-25 11:33AM	NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab (Zacks) +7.92%
11:20AM	Novavax slides after RFK Jr. casts doubts about COVID vaccine (TipRanks)
09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MCGLYNN MARGARET G	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	25,588	Jun 16 04:10 PM
Alton Gregg H	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	28,805	Jun 16 04:09 PM
King Rachel K.	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	25,190	Jun 13 09:41 PM
Rodgers Richard J	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	24,690	Jun 13 09:40 PM
MOTT DAVID M	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	60,890	Jun 13 09:39 PM
DOUGLAS RICHARD	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	54,340	Jun 13 09:36 PM
YOUNG JAMES F	Former Director	May 19 '25	Proposed Sale	7.59	10,000	75,883		May 19 04:37 PM
YOUNG JAMES F	Former Director	Apr 14 '25	Proposed Sale	6.10	4,000	24,406		Apr 14 04:19 PM
Trizzino John	President and COO	Mar 07 '25	Option Exercise	0.00	28,890	0	82,015	Mar 11 04:34 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 07 '25	Option Exercise	0.00	12,223	0	75,155	Mar 11 04:33 PM
Trizzino John	President and COO	Mar 01 '25	Option Exercise	0.00	48,000	0	76,310	Mar 04 06:47 PM
Casey Mark J	EVP, Chief Legal Officer	Mar 01 '25	Option Exercise	0.00	4,000	0	33,187	Mar 04 06:46 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 01 '25	Option Exercise	0.00	58,667	0	91,269	Mar 04 06:43 PM
Jacobs John C	President and CEO	Mar 01 '25	Option Exercise	0.00	83,334	0	175,183	Mar 04 06:42 PM
O'Hara Elaine	EVP, Chief Strategy Officer	Mar 01 '25	Option Exercise	0.00	59,600	0	73,825	Mar 04 06:39 PM
Jacobs John C	President and CEO	Jan 23 '25	Option Exercise	0.00	83,196	0	130,722	Jan 27 06:19 PM
Kelly James Patrick	EVP, CFO and Treasurer	Dec 31 '24	Option Exercise	0.00	35,000	0	49,508	Jan 03 05:41 PM
Rodgers Richard J	Director	Oct 29 '24	Option Exercise	0.00	3,800	0	14,270	Jan 02 04:52 PM
King Rachel K.	Director	Dec 13 '24	Sale	9.02	4,150	37,435	14,770	Jan 02 04:47 PM
YOUNG JAMES F	Director	Dec 31 '24	Sale	8.00	5,400	43,200	51,760	Jan 02 04:44 PM
YOUNG JAMES F	Director	Dec 24 '24	Sale	8.48	4,600	39,008	57,160	Jan 02 04:44 PM
YOUNG JAMES F	Director	Dec 24 '24	Proposed Sale	8.48	10,000	84,800		Dec 26 10:31 AM
Casey Mark J	EVP, Chief Legal Officer	Dec 11 '24	Option Exercise	0.00	41,900	0	41,900	Dec 13 05:24 PM
Rachel K. King	Board Member	Dec 13 '24	Proposed Sale	9.00	4,150	37,350		Dec 13 12:13 PM
Dubovsky Filip	Officer	Sep 18 '24	Proposed Sale	13.00	7,335	95,331		Sep 18 04:08 PM
Trizzino John	EVP, CCO and CBO	Aug 19 '24	Option Exercise	0.00	655	0	28,627	Aug 21 04:47 PM
Kelly James Patrick	EVP, CFO and Treasurer	Aug 16 '24	Option Exercise	12.96	2,367	30,676	15,652	Aug 20 05:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVAX

Novavax, Inc

Upgrade your FINVIZ experience